Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Forecast 2026–2030 Presenting Long-Term Industry Insights
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Between 2026 And 2030?
The messenger ribonucleic acid (mRNA) synthesis and manufacturing market has seen rapid expansion in recent years. Its value is projected to climb from $5.14 billion in 2025 to $5.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.6%. The historical growth trajectory can be linked to factors such as the restricted availability of mRNA synthesis platforms, early-stage research efforts in mRNA therapeutics, a reliance on small-scale laboratory production, emerging regulatory frameworks, and the high costs associated with purification and formulation services.
The messenger ribonucleic acid (mRNA) synthesis and manufacturing market is projected for significant expansion over the coming years. This market is anticipated to reach a valuation of $9.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. Key drivers for this growth during the forecast period include innovations in automated mRNA synthesis technology, the establishment of more commercial-scale mRNA production facilities, increased funding for vaccine and therapeutic development, a growing need for self-amplifying mRNA and new formulations, and an uptick in preclinical and clinical research partnerships. Prominent trends expected during this period involve wider adoption of GMP-compliant mRNA synthesis, escalating requirements for large-scale mRNA production, the broadening of mRNA therapeutic and vaccine portfolios, a heightened emphasis on purification, capping, and tailing services, and the increasing integration of mRNA-LNP formulations with comprehensive stability testing.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25832&type=smp
Which Drivers Are Supporting The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Growth?
The rising incidence of infectious diseases is anticipated to fuel the expansion of the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in the future. These disorders are defined as illnesses originating from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, encompassing conditions such as malaria, which are capable of spreading through direct or indirect means. The heightened prevalence of infectious diseases stems from rapid urbanization, contributing to greater population density and increased close human interaction, thereby accelerating the transmission of infections. Messenger ribonucleic acid (mRNA) synthesis and manufacturing play a crucial role in combating these diseases by allowing for the swift development and scalable creation of targeted vaccines and treatments that provoke a specific immune reaction. For example, data from October 2024, released by the World Health Organization, a Switzerland-based international public health organization, indicated that around 8.2 million individuals received a new tuberculosis diagnosis in 2023, an increase from approximately 7.5 million in 2022, establishing tuberculosis as the foremost infectious disease cause of death. Consequently, the expanding occurrence of infectious diseases is a significant impetus for the growth of the messenger ribonucleic acid (mRNA) synthesis and manufacturing market.
What Segment Categories Shape The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Segment Landscape?
The messenger ribonucleic acid (mrna) synthesis and manufacturing market covered in this report is segmented –
1) By Service Type: Messenger Ribonucleic Acid (mRNA) Drug Synthesis, Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis
2) By Scale Of Operation: Preclinical, Clinical, Commercial
3) By Therapeutic Area: Infectious Diseases, Oncology, Other Therapeutic Areas
4) By Application: Vaccine Production, Therapeutic Development, Drug Discovery, Other Applications
Subsegments:
1) By Messenger Ribonucleic Acid (mRNA) Drug Synthesis: Custom Messenger Ribonucleic Acid (mRNA) Synthesis, GMP-Grade Messenger Ribonucleic Acid (mRNA) Synthesis, Large-Scale Messenger Ribonucleic Acid (mRNA) Synthesis, Modified Messenger Ribonucleic Acid (mRNA) Synthesis, Capping And Tailing Services, Purification Services
2) By Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis: Preclinical Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, Clinical-Grade Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, GMP-Compliant Vaccine Batch Production, Self-Amplifying Messenger Ribonucleic Acid (mRNA) Synthesis, Messenger Ribonucleic Acid (mRNA)-LNP Formulation Services For Vaccines, Stability Testing And QC Services
Which Trends Are Guiding The Direction Of The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
Major companies engaged in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market are concentrating on the creation of innovative products, including co-transcriptional capping platforms, to accelerate preclinical research and alleviate regulatory challenges. A co-transcriptional capping platform is a specialized methodology that efficiently affixes a protective cap to messenger ribonucleic acid (mRNA) molecules during their synthesis, thereby enhancing mRNA stability, improving translation efficiency, and enabling better immunogenicity control. For instance, in May 2025, GenScript, a US-based life sciences research tools company, unveiled its good manufacturing practice (GMP)-like messenger ribonucleic acid (mRNA) manufacturing service. This particular service offers a scalable and regulatory-aware manufacturing solution designed to produce high-purity, functional mRNA for investigational new drug (IND)-enabling preclinical assessments, which include toxicology, biodistribution, and pharmacokinetics or pharmacodynamics (PK or PD) evaluations. It is established within cleanroom-compliant, International Organization for Standardization (ISO) 7-classified environments and incorporates patented co-transcriptional capping technology. This service delivers tailored mRNA in a timeframe as brief as seven weeks. This innovation effectively bridges the critical development divide between research-grade and full GMP manufacturing, allowing early-stage biotechnology and pharmaceutical companies to conduct regulatory-aligned studies without the substantial costs and delays typically associated with traditional GMP production.
Who Are The Companies Operating Across The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Value Chain?
Major companies operating in the messenger ribonucleic acid (mrna) synthesis and manufacturing market are Thermo Fisher Scientific Inc., Evonik Industries AG, Moderna Inc., BioNTech SE , AGC Biologics A/S, Eurofins Scientific SE, Lonza Group AG, Catalent Inc., WuXi Biologics (Cayman) Inc., Samsung Biologics Co Ltd., GenScript Biotech Corporation, Arcturus Therapeutics Holdings Inc., New England Biolabs Inc., CureVac N.V., Abzena plc, Creative Biolabs Inc., Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC
Get The Full Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Report:
Which Region Is The Largest In The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
North America was the largest region in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) synthesis and manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market 2026, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026
Gene Synthesis Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report
Mrna Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
